Search

everythinglearnresearchcommunity

for

Search:↓

Measuring minimal residual disease on day 15 helps identify high-risk leukemia patients.

Intralesional methotrexate effectively treats alopecia areata by reducing TNF-α levels, leading to hair regrowth.

Skin side effects from melanoma immunotherapy are common and may indicate better survival.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Thymoma-associated multiorgan autoimmunity can cause liver damage and affects multiple organs, with limited treatment options and a generally poor prognosis.

Combining gemcitabine with paclitaxel is more effective than with pemetrexed for advanced lung cancer.

JAK inhibitors have therapeutic potential but pose significant risks, requiring careful monitoring.

Tofacitinib is effective and safe for long-term treatment of severe alopecia areata, with many patients achieving complete hair regrowth.

Baricitinib and ritlecitinib are recommended for severe alopecia areata, with other treatments available off-label.

New strategies like vitamin A and dextromethorphan can help reduce methotrexate side effects and improve patient adherence.

A woman had severe reactions to methotrexate, including skin issues and organ problems, but improved after 38 days in the hospital.

Tacrolimus is an effective treatment for several skin conditions with fewer side effects than cyclosporine.

These new skin treatments are safer and more effective with minimal side effects.

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.

A rare skin reaction from cancer treatment was successfully managed with topical treatments and antihistamines.

Strontium ranelate helps cartilage growth by blocking a specific cell pathway.

Tofacitinib treatment significantly improved a patient's psoriasis, psoriatic arthritis, and alopecia universalis.

TS-13 effectively stops tumor growth and reduces chemotherapy side effects.

Blocking IL-8 can reduce skin rashes from cancer treatment.

Tildrakizumab significantly improved recalcitrant lichen planopilaris and frontal fibrosing alopecia.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

A patient with alopecia areata regrew hair after taking tofacitinib and showed changes in certain blood and skin markers.

Anifrolumab may help improve symptoms in patients with overlapping autoimmune diseases.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Oral Janus kinase inhibitors are effective for treating alopecia areata in adults.

JAK inhibitors are effective and safe for treating severe alopecia areata.

Leflunomide may lower alopecia areata risk, while other immunomodulators might increase it.